APA (7th ed.) Citation

Adamo, A., Frusteri, C., Pilotto, S., Caligola, S., Belluomini, L., Poffe, O., . . . Ugel, S. Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Adamo, Annalisa, et al. Immune Checkpoint Blockade Therapy Mitigates Systemic Inflammation and Affects Cellular FLIP-expressing Monocytic Myeloid-derived Suppressor Cells in Non-progressor Non-small Cell Lung Cancer Patients. Taylor & Francis Group.

MLA (9th ed.) Citation

Adamo, Annalisa, et al. Immune Checkpoint Blockade Therapy Mitigates Systemic Inflammation and Affects Cellular FLIP-expressing Monocytic Myeloid-derived Suppressor Cells in Non-progressor Non-small Cell Lung Cancer Patients. Taylor & Francis Group.